Aurora Cannabis (TSE:ACB) Trading 9.9% Higher – Time to Buy?

Aurora Cannabis Inc. (TSE:ACB) shares traded up 9.9% on Thursday . The company traded as high as C$6.92 and last traded at C$6.88. 267,087 shares traded hands during trading, a decline of 54% from the average session volume of 574,670 shares. The stock had previously closed at C$6.26.

Analyst Ratings Changes

ACB has been the topic of a number of analyst reports. ATB Capital cut their price target on Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday, December 17th. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. Finally, Atb Cap Markets raised Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th.

Aurora Cannabis Price Performance

The company has a debt-to-equity ratio of 18.72, a quick ratio of 2.48 and a current ratio of 3.42. The company has a 50-day moving average of C$6.87 and a 200-day moving average of C$6.98. The firm has a market capitalization of C$366.00 million, a price-to-earnings ratio of -8.26 and a beta of 2.71.

Insider Transactions at Aurora Cannabis

In other news, Senior Officer Andre Jerome sold 13,390 shares of the firm’s stock in a transaction dated Wednesday, February 12th. The stock was sold at an average price of C$9.30, for a total value of C$124,524.32.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.